Key statistics
On Friday, Eliem Therapeutics Inc (ELYM:NMQ) closed at 8.43, -27.01% below its 52-week high of 11.55, set on May 03, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 8.18 |
---|---|
High | 8.57 |
Low | 7.94 |
Bid | 8.00 |
Offer | 9.00 |
Previous close | 8.28 |
Average volume | 765.97k |
---|---|
Shares outstanding | 67.06m |
Free float | 60.10m |
P/E (TTM) | -- |
Market cap | 565.32m USD |
EPS (TTM) | -2.15 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
- Eliem Therapeutics to Participate at the Stifel 2024 Virtual Immunology and Inflammation Summit
- Eliem Therapeutics Announces Additions to its Leadership Team
- Eliem Therapeutics Reports Second Quarter Financial Results
- Eliem Therapeutics Announces its Addition to the Russell 2000® and Russell 3000® Indexes
- Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
- Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
More ▼